Latest News

ePAG Lead/Board Representatives Meeting in Paris 2024

To discuss and reorganise the activities within the ERN RARE-LIVER ePAG group, those responsible leads met in Paris at the end of October. Many ideas were exchanged and concrete action steps were defined.

Read More
ERN RARE-LIVER/EASL Position Paper on Rare primary liver cancers

In this position paper, an international panel of experts representing oncology, hepatology, pathology, radiology, surgery, and molecular biology has summarised the available information and evidence on the pathogenesis, diagnosis, and treatment of rare PLCs.

Read More
ERN RARE-LIVER Patient Representative at the EASL Congress 2024

Our patient representative Frank shares his impressions.

Read More
ERN RARE-LIVER Study - Survey for people with PSC, PBC or AIH

Social determinants of health (SDOH) are the conditions in which people are born, grow up, work and age. Studies suggest that SDOH influence the course of liver disease. However, this has not yet been studied in patients with autoimmune liver disease.

Read More
New ERN RARE-LIVER Paper on PSVD - Journal of Hepatology

Porto-sinusoidal vascular liver disorder (PSVD) is a rare liver condition that often leads to severe complications from portal hypertension and can reduce life expectancy.

Read More
Ocaliva for PBC - FDA Advisory Panel Voting, 13 September 2024

On 13 September 2024, a meeting of the Gastrointestinal Drugs Advisory Committee took place at which supplemental New Drug Application (sNDA) 207999 S-011, for OCALIVA (obeticholic acid) was discussed. The meeting was open to the public and was streamed live on the official FDA YouTube channel.

Read More
Veselina has had AIH since the age of three - this is how the right treatment changed her life

Please watch our new video describing Veselinas path and experience with the right treatment of her diagnosis.

Read More
Open Call for CPMS Helpdesk Fellows

We are pleased to announce an Open Call for all ERN RARE-LIVER members to propose a fellow within their institution to be part of the ERN RARE-LIVER CPMS Helpdesk team. The aim is to include three different young fellows from three different member centres, and to have both paediatric and adult representation.

Read More
For Physicians: New ERN RARE-LIVER Survey on Alcohol Use

ERN RARE-LIVER has constructed the survey “Counselling Young Adults With Liver Disease On Alcohol Use”. The survey will be open until 8 September, 2024. It consists of max. 10 pages and it will take 10 to 15 minutes to respond.

Read More
Launch of JARDIN Website

JARDIN is a Joint Action (JA) created to achieve the integration of European Reference Networks (ERNs) into National Healthcare Systems.

Read More
ERN RARE-LIVER call for workshops in 2025 is now open

The ERN RARE-LIVER plans to fund workshops of disease working groups and other initiatives in 2025.

Read More
Open letter to the European Commision

The rare disease community comes together in calling on the EU institutions and our national governments to stand by the European Reference Networks.

Read More
Communication to our Primary Biliary Cholangitis (PBC) patients – especially those receiving treatment with Ocaliva

On 28 June 2024, the European Medicines Agency (EMA) recommended revoking Ocaliva’s marketing authorization, citing that its risks outweigh the benefits.

Read More
ERN RARE-LIVER Webinar Series 25.06.2024: Liver cyst infection, the feared complication of cystic liver disease

This ERN RARE-LIVER Webinar on 25 June 2024 at 5 pm will focus on liver cyst infection, the feared complication of cystic liver disease.

Read More
COST ACTION EURO-VALDI-NET accepted

Congratulations to Pierre-Emmanuel Rautou and colleagues for their successful COST Action application! 134 researchers from 27 countries put together the EURO-VALDI-NET project on vascular liver diseases.

Read More
Meet our ERN RARE-LIVER team at EASL in Milano

Many thanks to all members and friends who visited us at EASL again this year for the interesting discussions and inspiring conversations.

Read More
Funding opportunity for clinical exchange!

The UEG (United European Gastroenterology) is offering clinical visiting fellowships to young doctors. You can apply to visit a European centre of excellence from a given list of hosts including a number of ERN RARE-LIVER members.

Read More
World Liver Day 2024, 19 April 2024

Your liver is an incredible organ, performing more than 500 vital functions, such as filtering toxins and aiding in digestion and metabolism. Yet, liver health is often overlooked. Each year, thousands of people are affected by liver disease. 1.5 billion people live with chronic liver disease, and 2 million lives are lost yearly. Early prevention can save many of these lives.

Read More
ERN RARE-LIVER Webinar Series 09.04.2024: Liver involvement in patients with Fontan-type circulation

This ERN RARE-LIVER Webinar on 9 April 2024 at 5pm will focus on liver involvement in patients with Fontan-type circulation. Fontan-associated liver disease is an orphan, novel, and challenging chronic liver disorder that appear in patients with univentricular cardiac malformations treated with Fontan surgery. ERN and EASL have recently launched a position document focusing on management of this particular and fragile population. We consider that the diffusion of this document conclusions is an unmet need that should be addressed.

Read More
Reasons why to take medication regularly

These tips are a team effort by Aida Regi Cosculluela and Dr Wiebke Papenthin, named patient representatives of the ERN RARE-LIVER Wilson working group and the ERN Youth Panel.

Read More
Meeting of the Named Patient Representatives

The last meeting of the Patient Representatives took place on 19 February 2024.

Read More
Funding opportunity for clinical exchange

The UEG (United European Gastroenterology) is offering clinical visiting fellowships to young doctors. You can apply to visit a European centre of excellence from a given list of hosts including a number of ERN RARE-LIVER member. This programme allows fellows

Read More
5-year evaluation of the European Commission

The European Commission praised the University Medical Center Hamburg-Eppendorf (UKE) and ERN RARE-LIVER for their outstanding performance in rare liver diseases.

Read More
New CPSS Position Paper

Congenital portosystemic shunts are often associated with systemic complications, the most challenging of which are liver nodules, pulmonary hypertension, endocrine abnormalities, and neurocognitive dysfunction.

Read More
5th Autoimmune Hepatitis Research Workshop on 27 & 28 June 2024

Following the previous successful iterations in Hamburg, Newcastle, Vienna and Maastricht, this in-person workshop focussed on advancing research in AIH, strengthening existing networks and building new ones.

Read More
Multidisciplinary aproach of patients with Fontan Circulation

Fontan Circulation CLASSROOM COURSE LIVE STREAMING BROADCAST

Read More
Illustrations of rare liver diseases in different languages

The graphic illustrations of various liver diseases presented at the Members Meeting have now been translated into various languages, e.g. Italian. We would be happy to translate and layout these helpful illustrations of various liver diseases into other languages of our Member Centres. Just let the office know what you need.

Read More
Overview Strategy Meeting 2023

On 11 and 12 December, the Management Board of ERN RARE-LIVER met in Hamburg to discuss the network's strategy for the next 4 years, the period covered by the next grant.

Read More
CPMS Achievements 2023

ERN RARE-LIVER and the CPMS helpdesk team would like to thank all ERN member centres for their commitment and effort in contributing to the Clinical Patient Management System (CPMS).

Read More
ERN RARE-LIVER Webinar Series 12.12.2023: Joint Webinar: Alpha-1 antitrypsin deficiency: a poster child for nucleic acid therapy

This ERN RARE-LIVER Webinar on 12. December 2023 at 5pm gave an exciting update to the Alpha-1 antitrypsin deficiency. The presentation covered "siRNA therapy in hepatology: a1-AT deficiency". The download for the Webinar on EASL Campus will follow soon.

Read More
News from the ERN RARE-LIVER Working Groups

What was going on in the various Working Groups of ERN RARE-LIVER in the last months? At this year's Members' Meeting in Hamburg, most of the working groups gave a brief overview of their activities and what they had achieved in the past 12 months.

Read More
Covid Update 2023

Autumn starts with new virus variants and a new vaccine - what do patients with rare liver diseases need to bear in mind?

Read More
Members' Meeting 2023

It was a great pleasure for the ERN RARE-LIVER office team to welcome all of you at this year’s Members’ Meeting in Hamburg.

Read More
New Video on how to use EBAR - The European Biliary Atresia Registry of the ERN RARE-LIVER

Biliary Atresia (BA) is a rare paediatric liver disease with an estimated prevalence of 1 / 14.000-21.000 births in Europe (~ 270 cases / year). Its aetiology is still unknown but recent studies favour an aetiology through microbe- or toxin-triggered immune dysregulation in liver and bile ducts leading to obliteration and fibrosis.

Read More
Research Workshop on Primary Sclerosing Cholangitis associated with Inflammatory Bowel Disease

This workshop took place 28 - 29 August in Padua discussing the impact of IBD activity on PSC and risk of colorectal cancer, treatment specificities in PSC-IBD, IBD course before and after liver transplantation and Pouchitis and pouch failure in PSC-IBD.

Read More
International Workshop: Focus on Vascular Liver Diseases

The INTERNATIONAL EXPLORATORY WORKSHOP supported by ERN RARE-LIVER, the Vascular Liver Diseases (VLD) Working group and VALDIG was an excellent opportunity to discuss and expand the possibilities of joint collaboration.

Read More
International Workshop: Focus on Vascular Liver Diseases

The INTERNATIONAL EXPLORATORY WORKSHOP supported by ERN RARE-LIVER, the Vascular Liver Diseases (VLD) Working group and VALDIG was an excellent opportunity to discuss and expand the possibilities of joint collaboration.

Read More
ERN RARE-LIVER at EASL CONGRESS in Vienna

Interesting talks and lectures at EASL CONGRESS in Vienna. Many of our members were involved as speakers doing presentations, talks and discussions, presenting cases to a wide audience of more than 8400 visitors registered. Ida Schregel had an excellent talk

Read More
New Patient representative: Aida Regi

Aida Regi from Spain was diagnosed with Wilson’s disease with neurological symptoms at the age of 13 and now has 25 years of experience living with Wilson’s disease.Aida is a Board member of the Spanish Association of Patients with Wilson’s

Read More
ESPGHAN Vienna 2023 May ERN RARE-LIVER Highlights

We had the last WG meeting within ESPGHAN Wednesday with a fully occupied room. We will have a new structure with ESPGHAN in the future, and this was discussed at the meeting. We also discussed ongoing projects with paediatric interest

Read More
New Patient Representative: Carmen Teemer

Carmen Teemer from Engstingen in Germany is our second new Patient Representativ.Working as a speech therapist, she is familiar with anatomy, medical terms and diseases that lead to speech and swallowing disorders.Carmen has been diagnosed with ADPKD and PLD in

Read More
PLD Working Group Meeting on June 6 in Nijmegen, the Netherlands

The PLD workgroup met on June 6 in Nijmegen, the Netherlands. During the program physicians, researchers and patient associations discussed the most recent PLD guidelines, the disease's impact on HRQoL and the current management options with their limitations.

Read More
First Youth Panel established by ERN RARE-LIVER

A workshop organised by the ERN RARE-LIVER Transition of Care working group, funded by the Networking Support Scheme of the European Joint Programme on Rare Diseases.

Read More
Report on 1st International Workshop on Future Therapies in Autoimmune Hepatitis

From 1 to 2 June, this workshop brought together 30 international experts from 10 different nations and highlighted the role of ERN RARE-LIVER as a collaborative network and registry platform for rare diseases such as AIH. Scientists and clinicians discussed the topic of Autoimmune Hepatitis.

Read More
Report on the Young Investigator Workshop on Basic Science and Translational immunology in PSC

On the Young Investigator Workshop on Basic Science and Translational Immunology in PSC on 25 to 26 May in Hamburg, young researchers fruitfully discussed the latest cutting-edge research and ideas at a joint meeting with the international PSC study group.The

Read More
New Hepatic Alveolar Echinococcosis Working Group

Alveolar Echinococcosis (AE) is a rare parasitic disease caused by the infection with the larval stage of the Echinococcus multilocularis tapeworm, known to be endemic in the northern hemisphere, mainly in central Europe and western China.

Read More
1st International Workshop on Future Therapies in Autoimmune Hepatitis

Friutfull 1st International Workshop on Future Therapies in Autoimmune Hepatitis with experts from various different scientific fields. The outstanding success of this workshop was the cooperation not only of clinicians but also of biostatisticians, patient advocates and medical officers from the FDA.

Read More
Biliary Atresia Register planned

Biliary Atresia (BA) is a rare liver disease of infancy with unclear etiology potentially leading to biliary cirrhosis and liver failure in early life. BA is still one of the main indications for paediatric liver transplantation. To meet this need, the prospective ERN RARE LIVER Biliary Atresia Registry (EBAR) was implemented in the up-and-running R-LIVER registry.

Read More
Young Investigator Workshop on Basic Science and Translational immunology in PSC

The workshop will foster international networking between participants and will present a forum to discuss ongoing research projects together with internationally recognized experts in basic science and immunology.

Read More
Unconventional treatment of Autoimmune Hepatitis

In order to assess the usage of "unconventional treatment" for autoimmune hepatitis (AIH) in our ERN community, we would like to perform an online survey to collect the experiences with these new treatments in our patients. We define "unconventional treatment" as new agents that have not been defined as 2nd or 3rd line treatment for AIH in the past and are used more in the fields of dermatology, rheumatology or inflammatory bowel disease.

Read More
Clinical exchange program – time for a review

The European Commission in cooperation with ECORYS, one of the oldest economic research and consulting companies in Europe, had launched a Clinical Exchange Program to share knowledge and stimulate collaborations between healthcare professionals within the ERNs.

Read More
Plasmapheresis Workshop, 22-23 November in Copenhagen

On 22 and 23 November, representatives from children's hospitals in Spain, Germany, UK and Denmark met for a networking and working meeting at Rigshospitalet, where they jointly took the first step toward establishing a protocol for the treatment of children with acute liver failure in the five European centres involved.

Read More
Acute liver inflammation (hepatitis) of unknown origin in children: an update by the European Reference Network ERN RARE-LIVER

Unexplained cases of acute liver inflammation in children, especially in the United Kingdom (UK) were reported earlier this year. In response, the European Reference Network on Hepatological Diseases (ERN RARE-LIVER) conducted a thorough investigation that did not confirm the alarming observation from the UK in other European countries.

Read More
New EASL Clinical Practice Guidelines on Sclerosing Cholangitis

We would like to draw your attention to the new EASL Clinical Practice Guideline on Sclerosing Cholangitis, which has been published in June 2022. We are grateful to all the authors and panelists, most of them from ERN centres.

Read More
New EASL Clinical Practice Guidelines on the management of cystic liver diseases

The advent of enhanced radiological imaging techniques has facilitated the diagnosis of cystic liver lesions and concomitantly, the evidence base supporting the management of these diseases has matured over the last decades.

Read More
Acute liver inflammation (hepatitis) of unknown origin in children: Cross-survey of the European Reference Network ERN RARE-LIVER

There has been concern regarding the frequency of unexplained cases of acute liver inflammation in children, especially in the United Kingdom (UK). In response, the European Reference Network on Hepatological Diseases (ERN RARE-LIVER) decided to conduct a thorough investigation. Conclusions from a survey conducted over 34 paediatric specialist liver centers from 22 European countries do not confirm the alarming observations from the UK in other European countries.

Read More
ERN RARE-LIVER statement on SARS-CoV2 booster vaccinations

In many countries booster vaccinations have become available, and therefore patients and families ask questions as to whether and when to receive a booster vaccine. As the evidence is scarce, and even more so in the field of rare diseases, it is not simple to give sound and scientifically based advice. Furthermore, availability of vaccines may differ. It remains a priority to vaccinate all unvaccinated at-risk people. Nonetheless, here we give some recommendations to the best of our knowledge as of November 2021:

Read More
The second Quality of Life ERN RARE-LIVER consensus meeting in Copenhagen

The second ERN RARE-LIVER Quality of Life (QoL) meeting began in Copenhagen on Friday 2 July. The meeting was held in a hybrid format with 11 on-site participants and additional online participants. The speakers were mainly from the Baltic Sea countries and we also welcomed participants from the United Kingdom and the Netherlands. There were both live and online talks on both days, followed by group discussions with the aim of capturing the most central issues raised and identifying potential future areas to elaborate upon, both clinically and scientifically. Many thanks to the organisers, Marianne Hørby, Henning Grønbæk and Henriette Ytting, and to all who participated.

Read More
SARS-CoV2 vaccines and other vaccinations for patients with rare liver diseases (available in 12 languages!)

Patients living with rare liver diseases are strongly encouraged to get vaccinated against COVID-19! This includes patients with decompensated liver disease and any rare liver disease such as PBC, PSC, AIH, vascular liver diseases, patients waiting for liver transplant and patients post-transplant. The vaccines appear safe. Talk to your healthcare provider if you are worried or unsure.

Read More
CPMS case presentation: marked ALP elevation in pregnancy

When a patient was presented to our Hepatology Department by the Maternity Clinic in Hamburg with an unusual cause of elevated ALP, opening a panel in CPMS allowed a case discussion which helped us to confirm the origin of the extremely high elevated ALP, and to estimate the risk to the mother and the unborn child. Continue for the full case report.

Read More
Lay Summary of the ERN RARE-LIVER Position Paper: Second-line and Third-line Therapy for Autoimmune Hepatitis

In collaboration with our patient representatives, we have produced a lay summary of the position paper, published recently as a result of the collaboration between the European Reference Network on Hepatological Diseases (ERN RARE-LIVER) and the International Autoimmune Hepatitis Group.

Read More
Quality of Life project presented at the EURODIS virtual meeting

There is some good news to share from the Quality of Life Working Group. They presented a poster on its two major projects at the online European Conference on Rare Diseases and Orphan Products in May. The projects are the

Read More
Patient information in light of the corona virus

Information for all patients with rare liver diseases (and, in case of children, their parents) Corona is not only dominating the media, Corona is increasingly in the mind of many of you worrying about vulnerability as a liver disease patient.

Read More
Coronavirus pandemic and immunosuppressed liver patients.

Lorenzo D’Antiga, MD Paediatric Hepatology, Gastroenterology and Transplantation Hospital Papa Giovanni XXIII, Bergamo Italy Following the outbreak in China, the Lombardy region of Italy has become one of the areas of highest incidence of severe acute respiratory syndrome Coronavirus 2

Read More
Quality of Life Workshop in Warsaw: 22 September 2020

The ERN Quality of Life (QoL) Workshop took place in Warsaw on September 22nd, 2020. The meeting was organized by our Warsaw colleagues Prof. Piotr Milkiewicz who coordinates ERN QoL Task Force and Dr. Maciej Janik, as well as by Prof. Ansgar W. Lohse and the ERN RARE-LIVER coordination team from Hamburg.

Read More
ERS Monograph on ɑ1-Antitrypsin Deficiency

This is an exciting time for those interested in ɑ1-antitrypsin deficiency (AATD): a greater understanding of the science underpinning pathophysiological mechanisms is translating into trials of innovative therapies, and knowledge about the role of augmentation therapy is changing with the

Read More
ERN RARE-LIVER Statutes
Read More